Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Short Interest Down 63.3% in March

Awakn Life Sciences Corp. (OTCMKTS:AWKNFGet Free Report) was the target of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 1,100 shares, a decrease of 63.3% from the February 29th total of 3,000 shares. Based on an average trading volume of 19,000 shares, the short-interest ratio is presently 0.1 days.

Awakn Life Sciences Stock Performance

OTCMKTS:AWKNF opened at $0.09 on Thursday. Awakn Life Sciences has a 52 week low of $0.04 and a 52 week high of $0.36. The stock’s 50-day moving average price is $0.10 and its 200-day moving average price is $0.12.

Awakn Life Sciences Company Profile

(Get Free Report)

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.

Featured Articles

Receive News & Ratings for Awakn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Awakn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.